Related references
Note: Only part of the references are listed.Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
Tian Hua et al.
CELL (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors
Wijnand J. C. van der Velden et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Anti-tumour actions of cannabinoids
Burkhard Hinz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li et al.
CELL (2019)
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar et al.
CELL (2019)
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential
Liang Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Aliphatic Azides as Selective Cysteine Labeling Reagents for Integral Membrane Proteins
Dennis Szymanski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Binding Site Characterization of AM1336, a Novel Covalent Inverse Agonist at Human Cannabinoid 2 Receptor, Using Mass Spectrometric Analysis
Srikrishnan Mallipeddi et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
The cannabinoid system and pain
Stephen G. Woodhams et al.
NEUROPHARMACOLOGY (2017)
Human Cannabinoid Receptor 2 Ligand-Interaction Motif: Transmembrane Helix 2 Cysteine, C2.59(89), as Determinant of Classical Cannabinoid Agonist Activity and Binding Pose
Han Zhou et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets
Srikrishnan Mallipeddi et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Biased agonism: An emerging paradigm in GPCR drug discovery
Zoran Rankovic et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua et al.
CELL (2016)
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues
Shashank Kulkarni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The role of kinetic context in apparent biased agonism at GPCRs
Carmen Klein Herenbrink et al.
NATURE COMMUNICATIONS (2016)
The Endocannabinoid System as a Therapeutic Target in Glaucoma
Elizabeth A. Cairns et al.
NEURAL PLASTICITY (2016)
The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
Eric W. Bow et al.
PERSPECTIVES IN MEDICINAL CHEMISTRY (2016)
Molecular-Interaction and Signaling Profiles of AM3677, a Novel Covalent Agonist Selective for the Cannabinoid 1 Receptor
David R. Janero et al.
ACS CHEMICAL NEUROSCIENCE (2015)
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner
C. M. Keenan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The Role of Binding Kinetics in GPCR Drug Discovery
David C. Swinney et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
3′-Functionalized Adamantyl Cannabinoid Receptor Probes
Go Ogawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Probing the Carboxyester Side Chain in Controlled Deactivation (-)-Δ8-Tetrahydrocannabinols
Spyros P. Nikas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Elham Khajehali et al.
MOLECULAR PHARMACOLOGY (2015)
2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective
Alexandros Makriyannis
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Drug-Target Residence Time-A Case for G Protein-Coupled Receptors
Dong Guo et al.
MEDICINAL RESEARCH REVIEWS (2014)
Controlled-Deactivation Cannabinergic Ligands
Rishi Sharma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Mass Spectrometry-based Proteomics of Human Cannabinoid Receptor 2: Covalent Cysteine 6.47(257)-Ligand Interaction Affording Megagonist Receptor Activation
Dennis W. Szymanski et al.
JOURNAL OF PROTEOME RESEARCH (2011)
hCB2 Ligand-Interaction Landscape: Cysteine Residues Critical to Biarylpyrazole Antagonist Binding Motif and Receptor Modulation
Richard W. Mercier et al.
CHEMISTRY & BIOLOGY (2010)
Novel 1′,1′-Chain Substituted Hexahydrocannabinols: 9/β-1-Hydroxy-3-(1-hexyl-cyclobut-l-yl)hexahydrocannabinol (AM2389) a Highly Potent Cannabinoid Receptor 1 (CB1) Agonist
Spyros P. Nikas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
Fraser F. Fleming et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis
David R. Janero et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
Ligand-Binding Architecture of Human CB2 Cannabinoid Receptor: Evidence for Receptor Subtype-Specific Binding Motif and Modeling GPCR Activation
Ying Pei et al.
CHEMISTRY & BIOLOGY (2008)
Cannabilactones: A novel class of CB2 selective agonists with peripheral analgesic activity
Atmaram D. Khanolkar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
C1′-cycloalkyl side chain pharmacophore in tetrahydrocannabinols
Demetris P. Papahatjis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
A concise methodology for the synthesis of (-)-Δ9-tetrahydrocannabinol and (-)-Δ9-tetrahydrocannabivarin metabolites and their regiospecifically deuterated analogs
Spyros P. Nikas et al.
TETRAHEDRON (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Cannabinoid receptors as therapeutic targets
Spiro Pavlopoulos et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
(-)-7′-isothiocyanato-11-hydroxy-1′,1-′dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor
RP Picone et al.
MOLECULAR PHARMACOLOGY (2005)
High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor
C Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
CB1 cannabinoid receptor ligands
GA Thakur et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'
DP Papahatjis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Share Paper
